RMED Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
N/A
Last Quarter
- $283.13
Past Year
- $45.92
Growth Past 5yrs
56.92%
Next Quarter
-
Estimate Next Year
-
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
N/A
0% Upside
Mean Price Target
N/A
0% Upside
Lowest Price Target
N/A
0% Upside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
RMED Earnings Per Share (EPS) History
According to financial reports, RMED (NYSE: RMED) reported an actual EPS of $-283.13428 for the quarter ending on Nov 13, 2023, compared to an estimated $-0.3, resulting in a 94278.09% surprise. In the prior quarter (Aug 24, 2023), RMED recorded an actual EPS of $-7.5 with a -2600.00% surprise. See RMED's full earnings history.
Earnings History
EPS Surprise Factor Analysis
RMED has experienced notable EPS surprises, with the latest quarter ending Nov 13, 2023 showing a 94278.09% beat. Previously, the quarter ending Aug 24, 2023 recorded a -2600.00% miss. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Nov 13, 2023 | -283.13428 | -0.3 | +94,278.09% |
| Aug 24, 2023 | -7.5 | 0.3 | -2,600.00% |
| Aug 21, 2023 | -7.5 | -0.3 | +2,400.00% |
| Jun 26, 2023 | -13.5 | 0.34 | -4,070.59% |
| Nov 14, 2022 | -3.86 | -8 | -51.75% |
| Aug 15, 2022 | -7.5 | -8 | -6.25% |
Frequently Asked Questions
Is RMED stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given RMED stock an average recommendation of
N/A. 0 analysts have given their ratings
to RMED out of which
0 analysts have given strong buy call,
0 analysts have given buy call,
0 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
- gives the stock implied downside
of roughly 0% over the next year or so.
What have analysts suggested for RMED highest price target?
Analysts suggest RMED's stock price would rise to a high of -.
What is the lowest price target analysts expect for RMED over the next year?
Within the next 12 months, analysts predict the RMED stock price could move to -.
What is the average target price for RMED?
RMED stock has an average analyst estimate of -.
At its current price, how far is RMED from its average target price?
RMED shares are currently trading 0% below this price target.
What were RMED’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at - $283.13 versus consensus estimates of - $0.30, and below the comparable year-ago quarter’s EPS of - $3.86.
What are the current estimates for quarterly and annual earnings per share?
RMED's forecasts by analysts estimating quarterly EPS at - and - for the whole year.
What has RMED's growth been in the past five years and what is expected in the next five years?
The analysts have projected N/A EPS growth for RMED in the next five years, compared to growth rates of 56.92% in the past five years.